268 related articles for article (PubMed ID: 19417720)
21. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia.
Kelesidis T; Humphries R; Ward K; Lewinski MA; Yang OO
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):286-90. PubMed ID: 21855248
[TBL] [Abstract][Full Text] [Related]
22. Optimizing therapy for MRSA pneumonia.
Skrupky LP; Micek ST; Kollef MH
Semin Respir Crit Care Med; 2007 Dec; 28(6):615-23. PubMed ID: 18095225
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.
Howden BP; Ward PB; Charles PG; Korman TM; Fuller A; du Cros P; Grabsch EA; Roberts SA; Robson J; Read K; Bak N; Hurley J; Johnson PD; Morris AJ; Mayall BC; Grayson ML
Clin Infect Dis; 2004 Feb; 38(4):521-8. PubMed ID: 14765345
[TBL] [Abstract][Full Text] [Related]
24. Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA).
Kaleem F; Usman J; Khalid A; Hassan A; Omair M
J Pak Med Assoc; 2011 Apr; 61(4):356-9. PubMed ID: 21465972
[TBL] [Abstract][Full Text] [Related]
25. [A case of cerebral abscess due to methicillin-resistant Staphylococcus aureus which is treated with linezolid + rifampin combination].
Sipahi OR; Cağıran I; Yurtseven T; Işıkgöz Taşbakan M; Arda B; Tünger A; Ulusoy S
Mikrobiyol Bul; 2010 Oct; 44(4):651-5. PubMed ID: 21063978
[TBL] [Abstract][Full Text] [Related]
26. [The second life of daptomycin: analysis of a successful come-back].
Decousser JW; Doucet Populaire F
Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
[No Abstract] [Full Text] [Related]
27. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
Kuo CC; Wu VC; Huang YT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2009 Jan; 33(1):96-8. PubMed ID: 18790610
[No Abstract] [Full Text] [Related]
28. Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.
Golden M; Shaib W; Havill N
Int J Antimicrob Agents; 2010 Mar; 35(3):306-8. PubMed ID: 20036108
[No Abstract] [Full Text] [Related]
29. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Leonard SN; Rybak MJ
J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
[TBL] [Abstract][Full Text] [Related]
30. Linezolid resistance in Staphylococcus epidermidis associated with a G2603T mutation in the 23S rRNA gene.
Lincopan N; de Almeida LM; Elmor de Araújo MR; Mamizuka EM
Int J Antimicrob Agents; 2009 Sep; 34(3):281-2. PubMed ID: 19376688
[No Abstract] [Full Text] [Related]
31. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S
Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Joson J; Grover C; Downer C; Pujar T; Heidari A
J Antimicrob Chemother; 2011 Sep; 66(9):2186-8. PubMed ID: 21653600
[No Abstract] [Full Text] [Related]
33. [Update of antimicrobial resistance in Gram-positive microorganisms].
Cercenado E
Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
[TBL] [Abstract][Full Text] [Related]
34. Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.
Schairer J; Sankri-Tarbichi AG; Fairfax MR; Salimnia H; Guzman JA
J Intensive Care Med; 2008; 23(5):338-41. PubMed ID: 18701528
[TBL] [Abstract][Full Text] [Related]
35. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.
Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H
Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857
[No Abstract] [Full Text] [Related]
36. [Prolonged treatment with linezolid with good hematologic tolerability].
Ramos A; García MJ; Blasco F; Valverde ML
Rev Esp Quimioter; 2004 Sep; 17(3):266-7. PubMed ID: 15619657
[No Abstract] [Full Text] [Related]
37. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
[TBL] [Abstract][Full Text] [Related]
38. Treatment of methicillin-resistant Staphylococcus aureus surgical site infections.
Santayana EM; Jourjy J
AACN Adv Crit Care; 2011; 22(1):5-12; quiz 14. PubMed ID: 21297385
[No Abstract] [Full Text] [Related]
39. Serious staphylococcal infections.
Backx M; Healy B
Clin Med (Lond); 2008 Oct; 8(5):535-8. PubMed ID: 18975490
[No Abstract] [Full Text] [Related]
40. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.
Twilla JD; Finch CK; Usery JB; Gelfand MS; Hudson JQ; Broyles JE
J Hosp Med; 2012 Mar; 7(3):243-8. PubMed ID: 22076962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
